Now more than ever, researchers are looking for stability when deciding where to place their next serum order. But it's not just a stable supplier that counts in pharma manufacturing. A stable supply chain matters, too.
A vertically integrated supply chain supports a consistent, long-term stock for vaccine manufacturing and the manufacturing of other biologics. But in times of constrained worldwide inventory — such as during a pandemic — not every supplier can deliver.
That's why labs should be especially prudent about where their serum comes from, says Mark Koza, business manager of serum at Corning Life Sciences.
"Demand for serum to support the manufacture of biologicals had been surging even before COVID-19, but the pandemic added some gas to the fire," Koza said. "With constrained supply now affecting some of the biggest suppliers, manufacturers are looking at different players to qualify into their processes. Verifying supply chain consistency, traceability, and quality will continue to be key."
To make sure that quality serum will be there when they need it, manufacturers need to ask their suppliers some pointed questions before stocking or restocking their lab. Here are six they can start with.